ArticleMaterials today. Bio2026

Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy.

Maojin Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.